GI reps with endoscopy-suite access.
IBD biologics, GI devices, endoscopy capital equipment, and motility diagnostics.
Gastroenterology dynamics.
Gastroenterology is one of the most consolidated specialties in medicine — large GI super-groups (GI Alliance, US Digestive Health, Gastro Health) now control the buying motion across regional markets. Endoscopy is the procedural anchor — colonoscopy, EGD, ERCP — and the category economics live at the endoscopy-center level. IBD biologics are the highest-stakes pharmaceutical conversation, with payer-aware buy-and-bill economics dominating.
Why this specialty fits Solara reps.
Solara GI reps carry portfolios that respect the super-group buying motion — biologics alongside endoscopy devices and motility diagnostics. Per-platform economics compound across the practices within a super-group.
Apply to the networkWhat Solara delivers for gi launches.
Manufacturers in GI need coverage at the large super-groups (GI Alliance, US Digestive Health, etc.) and at independent gastroenterology practices. Solara's network covers both, with adoption telemetry at the super-group, practice, and physician level.
Book a working sessionWhat GI reps see most.
- ·Inflammatory bowel disease (Crohn's, UC)
- ·GERD / Barrett's esophagus
- ·Colorectal cancer screening
- ·Hepatitis C
- ·Non-alcoholic steatohepatitis (NASH/MASH)
- ·Functional bowel disorders (IBS)
- ·Pancreatic insufficiency
Procedures that anchor the buying motion.
- 43239Upper GI endoscopy with biopsy
- 45378Colonoscopy, diagnostic
- 43235Esophagogastroduodenoscopy
- 43274ERCP with stent placement
- 91110Capsule endoscopy
Product categories most relevant to gi.
Common questions about gi on Solara.
- Does Solara cover the large GI super-groups?
Yes. GI Alliance, US Digestive Health, Gastro Health, and the regional super-groups are part of the network coverage. Reps maintain relationships at the super-group medical-director and pharmacy-director level alongside individual gastroenterologists.
- Can Solara support IBD biologic launches with payer-aware messaging?
Yes. IBD biologics are one of the highest-touch pharmaceutical conversations in the specialty, and reps are trained on payer step-therapy, prior-authorization workflows, and the patient-support resources specific to each biologic class.
- How does Solara handle the endoscopy-center buying motion for devices?
Endoscopy device sales happen at the endoscopy-center level — purchasing committees that span multiple practices. Reps cover those committees alongside individual physicians, with administrator-side relationships explicitly part of the workflow.
- What targeting data is used for gastroenterology?
Procedural volume by CPT, super-group affiliation, endoscopy-center ownership, IBD biologic prescribing patterns where reportable, and payer mix. ICP scoring surfaces practices and physicians with the right procedural and prescribing profile.
See your gi territory.
Drop in your metro on the territory preview tool — we'll surface the top 50 physicians most likely to adopt your product, scored on five signals.